期刊文献+

产超广谱β-内酰胺酶大肠埃希菌耐药性分析 被引量:7

Analysis of antibiotic resistance of extended-spectrum β-lactamases-producing Escherichia coli strains
下载PDF
导出
摘要 目的:了解产超广谱β-内酰胺酶(ESBLs)大肠埃希菌的耐药性,为临床合理选用抗生素提供依据。方法:2005年9月~2006年6月,收集临床分离产ESBLs大肠埃希菌63株,采用琼脂平皿稀释法进行MIC测定。结果:产ESBLs大肠埃希菌对碳青霉烯类和哌拉西林/他唑巴坦普遍敏感,对哌拉西林和喹诺酮类耐药率分别为98.41%和90.48%,对头孢吡肟、头孢哌酮/舒巴坦、头孢他啶、头孢西丁、头孢噻肟和头孢曲松耐药率依次为34.92%、36.51%、44.45%、55.56%、82.54%和84.13%。结论:我院产ESBLs大肠埃希菌耐药明显。 Objective : To study the resistance of the extended-spectrum β-lactamases ( ESBLs ) -producing Escherichia coli ( E. coli) strains and to provide basis for clinical therapy, nethods:Agar dilution method was used to determine MICs of 13 antibiotics against 63 strains of ESBLs-producing E. coli which were collected between October 2005 and June 2006 in our hospital. Results: ESBLsproducing E. coli was generally sensitive to carbopenems and piperacillin/tazobatan, while most strains were highly resistant to piperacillin and quinolones. The rate of resistance to cefepime, ceforazone/sulbactam, ceftazidime, cefoxitin, ceftaxime and ceftriaxone were 34.92% ,36.51%, 44.45 %, 55.56% , 82.54% and 84. 13%, respectively. Conclusions : ESBLs-producing E. coil strains are highly resistant to antibiotics in our hospital.
出处 《蚌埠医学院学报》 CAS 2008年第5期531-532,共2页 Journal of Bengbu Medical College
关键词 大肠埃希菌 超广谱Β-内酰胺酶 耐药性 微生物 琼脂稀释法 E. coli extended-spectrum β-lactamases drug resistance, macrobial agar dilution method
  • 相关文献

参考文献5

二级参考文献22

  • 1牟立东,张立平.产超广谱β-内酰胺酶细菌的检测及耐药性分析[J].中国现代应用药学,2005,22(1):77-78. 被引量:5
  • 2邱文影,钟国权.产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的耐药性分析[J].中华医院感染学杂志,2005,15(12):1415-1416. 被引量:49
  • 3戴自英.实用抗菌药物学[M].上海:上海科学技术出版社,2000.189.
  • 4张秀珍.当代细菌检验与临床[M].北京:人民卫生出版社,2000.37-43.
  • 5National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing[S].Ninth informational supplement.M 100-S9.Pennsylvania:NCCLS,1999.17-103.
  • 6National Committee for Clinical Laboratory Standards.Per formance standards for antimicrobial susceptibility testing[M].9th Informational susplemented.Wayne PA:National Committee for Clinical Standard,1999.19(1):36.
  • 7Bradford PA.Extended-spectrum beta-lactamases in the 21st century:characterization,epidemiology and detection of impor tant resistance threat[J].Clin Microbiol Rev,2001,14 (4):933-951.
  • 8Xiong Z,Zhu D,Zhang Y,et al.Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates[J].Chin med J,2002,82(21):1476.
  • 9Gales A C,Jones R N,Turnidge J,et al.Characterization of pseudomonas aeruginosa isolates:occurrence rates,antimicrobial susceptibility patterns,and molecular typing in the giobal SENTRY antimicrobial surveillance program,1997-1999[J].Clin Infect Dis,2001,32 (Suppl 2):S146-55.
  • 10Hsueh P R,Liu Y C,Yang D,et al.Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in taiwan[J].Microb Drug Resist,2001,7 (4):373-82.

共引文献65

同被引文献52

引证文献7

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部